AirSculpt Technologies, Inc. (AIRS)

Market Cap	463.28M
Revenue (ttm)	165.11M
Net Income (ttm)	-14.51M
Shares Out	62.44M
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	868.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	649,762
Open	7.37
Previous Close	7.31
Day's Range	7.16 - 7.62
52-Week Range	1.53 - 9.20
Beta	2.54
Analysts	Hold
Price Target	3.75 (-49.46%)
Earnings Date	Nov 7, 2025

About AIRS

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and Air...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 29, 2021
• Employees: 422
• Stock Exchange: NASDAQ
• Ticker Symbol: AIRS
• Website: https://airsculpt.com

Financial Performance

In 2024, AirSculpt Technologies's revenue was $180.35 million, a decrease of -7.95% compared to the previous year's $195.92 million. Losses were -$8.25 million, 84.2% more than in 2023.

Analyst Forecast

According to 3 analysts, the average rating for AIRS stock is "Hold." The 12-month stock price target is $3.75, which is a decrease of -49.46% from the latest price.

Price Target

$3.75

(-49.46% downside)

Analyst Consensus: Hold